E Fund Management Co., Ltd. Blueprint Medicines Corp Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 7,508 shares of BPMC stock, worth $851,407. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,508
Previous 5,768
30.17%
Holding current value
$851,407
Previous $621,000
11.76%
% of portfolio
0.04%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding BPMC
# of Institutions
354Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$758 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$754 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$611 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$450 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$314 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.77B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...